FdaApplication
BLA 761028
Identifiers
- fda_app_no: BLA761028
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 2017-09-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MVASI | BEVACIZUMAB-AWWB | 400MG/16ML (25MG/ML) | INJECTABLE;INJECTION |
| MVASI | BEVACIZUMAB-AWWB | 100MG/4ML (25MG/ML) | INJECTABLE;INJECTION |
2 products